ArticleTheranostics2026

Novel nastorazepide-based radioligands demonstrate effective cholecystokinin-2 receptor targeting with potential for theranostic applications.

Lennart Bohrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.